Hepatitis Virus C NS3 Protease Inhibitor 2 is a peptide inhibitor derived from a product that targets the NS3 protease of the hepatitis C virus (HCV). Its inhibitory activity against the NS3 protease is characterized by a Ki value of 41 nM.
TAPI-2 is a broad-spectrum inhibitor of MMP (IC50: 20 μM), tumour necrosis factorα-converting enzyme (TACE) and a disintegrin and metalloproteinase (ADAM).
LY 3000328 (Cathepsin S inhibitor) 是 Cathepsin S 的选择性抑制剂,抑制人和小鼠Cat S 的IC50分别为7.7,1.67 nM。LY 3000328 (Cathepsin S inhibitor)可以通过抑制 Cathepsin S 介导的细胞外基质蛋白、弹性蛋白和胶原蛋白的降解来减缓或阻止腹主动脉瘤 (AAA) 扩张和/或降低 AAA 破裂的风险。